Chaoming Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chaoming Liu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Huaguo Liang
Hefei University of Technology
2 shared publications - Hui Xu
Anhui University of Science and Technology
2 shared publications - Ruijun Ma
Anhui University of Science and Technology
2 shared publications - Cheng Huang
Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei City 112304, Taiwan
1 shared publication Jiali Xie
Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, China
1 shared publication- Jiuqi Li
School of Computer Science and Engineering, Anhui University of Science and Technology, Huainan, China
1 shared publication
Latest Publications
- 10 April 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Device and Materials Reliability
- Vol. 24 (2) , 302-312
A Low-Area Overhead and Low-Delay Triple-Node-Upset Self-Recoverable Design Based on Stacked Transistors
With the aggressive scaling in the feature size of transistors, single-event triple-node-upsets (TNUs) induced by charge sharing in CMOS circuits have become a significant reliability problem. In this paper, based on N-type stacked transistors, a TNU self-recovery latch called LORD-TNU is proposed. Utilizing the stacked transistors to reduce the count of sensitive nodes in the latch. In addition, we use three modules to protect each other. In the event of a soft error in one module, the remaining modules can restore the corrupted module. This design not only saves delay overhead but also minimizes area overhead. Simulation results show that compared with the four typical TNU hardened latches, the proposed LORD-TNU latch reduces area overhead by 49.76%, power consumption by 56.07%, delay by 40.17%, and the power-delay-product (PDP) by 72.56% on average, respectively. Moreover, the robustness of our LORD-TNU latch is confirmed by comprehensive PVT (Process, Voltage, Temperature) and Monte Carlo simulations, demonstrating its stability across a range of process corners, supply voltage, and temperature variations.
- 10 April 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Device and Materials Reliability
- Vol. 24 (2) , 302-312
A Low-Area Overhead and Low-Delay Triple-Node-Upset Self-Recoverable Design Based on Stacked Transistors
With the aggressive scaling in the feature size of transistors, single-event triple-node-upsets (TNUs) induced by charge sharing in CMOS circuits have become a significant reliability problem. In this paper, based on N-type stacked transistors, a TNU self-recovery latch called LORD-TNU is proposed. Utilizing the stacked transistors to reduce the count of sensitive nodes in the latch. In addition, we use three modules to protect each other. In the event of a soft error in one module, the remaining modules can restore the corrupted module. This design not only saves delay overhead but also minimizes area overhead. Simulation results show that compared with the four typical TNU hardened latches, the proposed LORD-TNU latch reduces area overhead by 49.76%, power consumption by 56.07%, delay by 40.17%, and the power-delay-product (PDP) by 72.56% on average, respectively. Moreover, the robustness of our LORD-TNU latch is confirmed by comprehensive PVT (Process, Voltage, Temperature) and Monte Carlo simulations, demonstrating its stability across a range of process corners, supply voltage, and temperature variations.
- 1 February 2024
- Published by Springer Nature in Journal of Electronic Testing
- Vol. 40 (1) , 45-60
A High-Performance Quadruple-Node-Upset-Tolerant Latch Design and an Algorithm for Tolerance Verification of Hardened Latches
- 1 February 2024
- Published by Springer Nature in Journal of Electronic Testing
- Vol. 40 (1) , 45-60
A High-Performance Quadruple-Node-Upset-Tolerant Latch Design and an Algorithm for Tolerance Verification of Hardened Latches
- Open Access
- 22 February 2021
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15
Icaritin Alleviates Glutamate-Induced Neuronal Damage by Inactivating GluN2B-Containing NMDARs Through the ERK/DAPK1 Pathway
Excitatory toxicity due to excessive glutamate release is considered the core pathophysiological mechanism of cerebral ischemia. It is primarily mediated by N-methyl-D-aspartate receptors (NMDARs) on neuronal membranes. Our previous studies have found that icaritin (ICT) exhibits neuroprotective effects against cerebral ischemia in rats, but the underlying mechanism is unclear. This study aims to investigate the protective effect of ICT on glutamate-induced neuronal injury and uncover its possible molecular mechanism. An excitatory toxicity injury model was created using rat primary cortical neurons treated with glutamate and glycine. The results showed that ICT has neuroprotective effects on glutamate-treated primary cortical neurons by increasing cell viability while reducing the rate of lactate dehydrogenase (LDH) release and reducing apoptosis. Remarkably, ICT rescued the changes in the ERK/DAPK1 signaling pathway after glutamate treatment by increasing the expression levels of p-ERK, p-DAPK1 and t-DAPK1. In addition, ICT also regulates NMDAR function during glutamate-induced injury by decreasing the expression level of the GluN2B subunit and enhancing the expression level of the GluN2A subunit. As cotreatment with the ERK-specific inhibitor U0126 and ICT abolishes the beneficial effects of ITC on the ERK/DAPK1 pathway, NMDAR subtypes and neuronal cell survival, ERK is recognized as a crucial mediator in the protective mechanism of ICT. In conclusion, our findings demonstrate that ICT has a neuroprotective effect on neuronal damage induced by glutamate, and its mechanism may be related to inactivating GluN2B-containing NMDAR through the ERK/DAPK1 pathway. This study provides a new clue for the prevention and treatment of clinical ischemic cerebrovascular diseases.
- 22 February 2021
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15
Open AccessIcaritin Alleviates Glutamate-Induced Neuronal Damage by Inactivating GluN2B-Containing NMDARs Through the ERK/DAPK1 Pathway
Excitatory toxicity due to excessive glutamate release is considered the core pathophysiological mechanism of cerebral ischemia. It is primarily mediated by N-methyl-D-aspartate receptors (NMDARs) on neuronal membranes. Our previous studies have found that icaritin (ICT) exhibits neuroprotective effects against cerebral ischemia in rats, but the underlying mechanism is unclear. This study aims to investigate the protective effect of ICT on glutamate-induced neuronal injury and uncover its possible molecular mechanism. An excitatory toxicity injury model was created using rat primary cortical neurons treated with glutamate and glycine. The results showed that ICT has neuroprotective effects on glutamate-treated primary cortical neurons by increasing cell viability while reducing the rate of lactate dehydrogenase (LDH) release and reducing apoptosis. Remarkably, ICT rescued the changes in the ERK/DAPK1 signaling pathway after glutamate treatment by increasing the expression levels of p-ERK, p-DAPK1 and t-DAPK1. In addition, ICT also regulates NMDAR function during glutamate-induced injury by decreasing the expression level of the GluN2B subunit and enhancing the expression level of the GluN2A subunit. As cotreatment with the ERK-specific inhibitor U0126 and ICT abolishes the beneficial effects of ITC on the ERK/DAPK1 pathway, NMDAR subtypes and neuronal cell survival, ERK is recognized as a crucial mediator in the protective mechanism of ICT. In conclusion, our findings demonstrate that ICT has a neuroprotective effect on neuronal damage induced by glutamate, and its mechanism may be related to inactivating GluN2B-containing NMDAR through the ERK/DAPK1 pathway. This study provides a new clue for the prevention and treatment of clinical ischemic cerebrovascular diseases.